Role of G Protein-Coupled Estrogen Receptor in Digestive System Carcinomas: A Minireview

Yu-an Qiu,Jianping Xiong,Tenghua Yu
DOI: https://doi.org/10.2147/OTT.S291896
IF: 4
2021-04-15
OncoTargets and Therapy
Abstract:Yu-an Qiu, 1 Jianping Xiong, 2 Tenghua Yu 3 1 Department of Critical Care Medicine, Jiangxi Cancer Hospital, Nanchang University Cancer Hospital, Nanchang, 330029, People's Republic of China; 2 Department of Oncology, The First Affiliated Hospital of Nanchang University, Nanchang, 330006, People's Republic of China; 3 Department of Breast Surgery, Jiangxi Cancer Hospital, Nanchang University Cancer Hospital, Nanchang, 330029, People's Republic of China Correspondence: Tenghua Yu Tel/Fax +86-791-88319832 Email Digestive system carcinomas are one of the leading causes of cancer-related deaths worldwide. G protein-coupled estrogen receptor (GPER), a novel estrogen receptor, has been recognized as an important mediator in numerous cancer types. Recently, the function and clinical significance of GPER in digestive system carcinomas has been a subject of interest. Increasing evidence has revealed that GPER plays an important role as a potential biomarker in digestive system carcinomas. This work summarizes the recent literature and focuses on the emerging functional role of GPER in digestive system carcinomas, including gastric cancer, hepatocellular carcinoma, pancreatic cancer, and colorectal cancer. The potential application of GPER in novel strategies for the diagnosis and treatment of digestive system carcinomas is discussed and highlighted. Keywords: GPER, digestive system carcinomas, prognostic indicator, therapeutic target
oncology,biotechnology & applied microbiology
What problem does this paper attempt to address?